Santa Clara, CA, United States of America

Gary Charles Look

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 161(Granted Patents)


Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: Innovator Gary Charles Look: Pioneering Treatments for Neurodegenerative Diseases

Introduction

Gary Charles Look, an accomplished inventor based in Santa Clara, CA, is recognized for his significant contributions to the field of neurodegenerative disease treatment. With an impressive portfolio of 12 patents, Look has focused his research and innovations on developing pharmaceutical compositions that target conditions such as Alzheimer's disease and cognitive decline.

Latest Patents

Among his notable patents, Gary Look has developed compositions for treating neurodegenerative diseases. These compositions consist of novel compounds characterized by specific formulas targeting various receptors. His innovative approach encompasses pharmaceutical compositions that are not only effective but also provide methods for their use in treating disorders related to cognitive decline.

Another of Look's significant inventions involves isoindoline compositions, which act as sigma-2 receptor antagonist compounds. These innovations aim to inhibit Abeta-associated synapse loss and synaptic dysfunction in neuronal cells. The methods he has formulated are geared towards modulating membrane trafficking changes in neuronal cells, offering new possibilities in treating cognitive decline associated with Abeta pathology.

Career Highlights

Gary Charles Look has made remarkable advancements in his career, particularly while working with recognized companies like Cognition Therapeutics, Inc. and Affymax Technologies, N.V. His work has consistently revolved around the intersection of innovative chemistry and therapeutic applications, demonstrating his dedication to addressing pressing medical challenges.

Collaborations

Throughout his career, Gary Look has collaborated with distinguished professionals, including Gilbert M. Rishton and Susan M. Catalano. These partnerships have enriched his research endeavors, contributing to the development of cutting-edge solutions for neurodegenerative diseases.

Conclusion

In conclusion, Gary Charles Look represents a beacon of innovation in the field of neurodegenerative disease treatment. His commitment to developing novel pharmaceutical compositions and his extensive patent portfolio highlight his role as a pivotal inventor in this critical area of research. Through his work, Gary Look continues to inspire advancements that may ultimately transform the lives of those affected by cognitive decline and related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…